Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
300259.SZ Stock Summary
Top 10 Correlated ETFs
300259.SZ
In the News
300259.SZ Financial details
Company Rating
Neutral
Market Cap
3.86B
Income
218.8M
Revenue
1.08B
Book val./share
2.43
Cash/share
1.16
Dividend
0.15
Dividend %
4.13%
Employees
1.3K
Optionable
No
Shortable
Yes
Earnings
30 Mar 2024
P/E
19.19
Forward P/E
-
PEG
-4.15
P/S
3.88
P/B
1.49
P/C
2.79
P/FCF
54.09
Quick Ratio
4.07
Current Ratio
4.85
Debt / Equity
0.01
LT Debt / Equity
0
-
-
EPS (TTM)
0.19
EPS next Y
-
EPS next Q
-
EPS this Y
-40%
EPS next Y
-
EPS next 5Y
165.67%
EPS last 5Y
10.07%
Revenue last 5Y
5.57%
Revenue Q/Q
16.82%
EPS Q/Q
-4.27%
-
-
-
-
SMA20
7.52%
SMA50
-9.86%
SMA100
-7.58%
Inst Own
-
Inst Trans
-
ROA
7%
ROE
8%
ROC
0.09%
Gross Margin
43%
Oper. Margin
22%
Profit Margin
20%
Payout
26%
Shs Outstand
1.16B
Shs Float
1B
-
-
-
-
Target Price
-
52W Range
2.32-4.13
52W High
-19%
52W Low
+62%
RSI
51.62
Rel Volume
0.57
Avg Volume
9.99M
Volume
5.74M
Perf Week
-2.7%
Perf Month
30.65%
Perf Quarter
-
Perf Half Y
-10.25%
-
-
-
-
Beta
0.339
-
-
Volatility
0.07%, 0.15%
Prev Close
2.53%
Price
3.24
Change
0%
300259.SZ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.75 | 1.01 | 1.02 | 1.02 | 0.97 | |
Net income per share | 0.13 | 0.23 | 0.32 | 0.35 | 0.21 | |
Operating cash flow per share | 0.12 | 0.21 | 0.25 | 0.19 | 0.25 | |
Free cash flow per share | 0.07 | 0.11 | 0.21 | 0.16 | 0.14 | |
Cash per share | 0.32 | 1.08 | 1.32 | 1.46 | 1.42 | |
Book value per share | 1.68 | 1.87 | 2.16 | 2.42 | 2.47 | |
Tangible book value per share | 1.59 | 1.74 | 2.07 | 2.27 | 2.33 | |
Share holders equity per share | 1.68 | 1.87 | 2.16 | 2.42 | 2.47 | |
Interest debt per share | 0.01 | 0 | 0.02 | 0.02 | 0.11 | |
Market cap | 2.94B | 5.1B | 5.81B | 6.12B | 3.85B | |
Enterprise value | 2.61B | 4.82B | 5.29B | 5.32B | 3.36B | |
P/E ratio | 19.71 | 18.66 | 15.33 | 14.8 | 15.68 | |
Price to sales ratio | 3.44 | 4.32 | 4.87 | 5.13 | 3.44 | |
POCF ratio | 21.8 | 20.75 | 19.75 | 27.78 | 13.5 | |
PFCF ratio | 35.1 | 37.95 | 23.17 | 32.76 | 24.45 | |
P/B Ratio | 1.52 | 2.33 | 2.3 | 2.16 | 1.34 | |
PTB ratio | 1.52 | 2.33 | 2.3 | 2.16 | 1.34 | |
EV to sales | 3.05 | 4.08 | 4.43 | 4.46 | 3 | |
Enterprise value over EBITDA | 11.01 | 13.15 | 12.82 | 18.59 | 8.41 | |
EV to operating cash flow | 19.34 | 19.62 | 17.99 | 24.18 | 11.77 | |
EV to free cash flow | 31.14 | 35.88 | 21.1 | 28.51 | 21.33 | |
Earnings yield | 0.05 | 0.05 | 0.07 | 0.07 | 0.06 | |
Free cash flow yield | 0.03 | 0.03 | 0.04 | 0.03 | 0.04 | |
Debt to equity | 0.01 | 0 | 0.01 | 0.01 | 0.01 | |
Debt to assets | 0.01 | 0 | 0.01 | 0.01 | 0.01 | |
Net debt to EBITDA | -1.4 | -0.76 | -1.26 | -2.77 | -1.23 | |
Current ratio | 4 | 4.06 | 4.72 | 5.17 | 4.71 | |
Interest coverage | 154.14 | 1.8K | 2.09K | 836.29 | 3.94 | |
Income quality | 0.86 | 0.87 | 0.75 | 0.53 | 1.16 | |
Dividend Yield | 0.02 | 0 | 0.01 | 0.02 | 0.05 | |
Payout ratio | 0.37 | 0.04 | 0.15 | 0.25 | 0.71 | |
Sales general and administrative to revenue | 0.03 | 0.02 | 0.02 | 0.02 | 0.01 | |
Research and developement to revenue | 0.07 | 0.07 | 0.07 | 0.08 | 0.08 | |
Intangibles to total assets | 0.07 | 0.08 | 0.05 | 0.05 | 0.05 | |
Capex to operating cash flow | -0.38 | -0.45 | -0.15 | -0.15 | -0.45 | |
Capex to revenue | -0.06 | -0.09 | -0.04 | -0.03 | -0.11 | |
Capex to depreciation | -1.42 | -3.09 | -1.18 | -0.99 | -3.84 | |
Stock based compensation to revenue | 0 | 0 | -0.01 | 0 | 0.01 | |
Graham number | 2.22 | 3.13 | 3.97 | 4.39 | 3.43 | |
ROIC | 0.08 | 0.13 | 0.15 | 0.08 | 0.11 | |
Return on tangible assets | 0.06 | 0.11 | 0.13 | 0.13 | 0.08 | |
Graham Net | 0 | 1.07 | 1.39 | 1.49 | 1.43 | |
Working capital | 1.33B | 1.56B | 1.96B | 2.07B | 1.98B | |
Tangible asset value | 1.83B | 2.03B | 2.42B | 2.66B | 2.7B | |
Net current asset value | 1.29B | 1.52B | 1.92B | 2.04B | 1.95B | |
Invested capital | 0.01 | 0 | 0.01 | 0.01 | 0.01 | |
Average receivables | 189.37M | 260.61M | 622.84M | 637.97M | 561.58M | |
Average payables | 177.32M | 223.16M | 253.52M | 283.7M | 337.37M | |
Average inventory | 197.35M | 250.65M | 247.36M | 260.14M | 298.29M | |
Days sales outstanding | 0 | 161.11 | 221.37 | 168.7 | 186.03 | |
Days payables outstanding | 164.12 | 154.07 | 141.09 | 176.66 | 209.75 | |
Days of inventory on hand | 190.05 | 168.97 | 120.59 | 170.88 | 170.3 | |
Receivables turnover | 3587200.95B | 2.27 | 1.65 | 2.16 | 1.96 | |
Payables turnover | 2.22 | 2.37 | 2.59 | 2.07 | 1.74 | |
Inventory turnover | 1.92 | 2.16 | 3.03 | 2.14 | 2.14 | |
ROE | 0.08 | 0.13 | 0.15 | 0.15 | 0.09 | |
Capex per share | -0.04 | -0.1 | -0.04 | -0.03 | -0.11 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.4 | 0.3 | 0.16 | 0.22 | 0.26 | |
Net income per share | 0.05 | 0.07 | 0.04 | 0.04 | 0.04 | |
Operating cash flow per share | 0.05 | 0.07 | 0.04 | -0.01 | 0.06 | |
Free cash flow per share | 0 | 0.05 | 0.01 | -0.03 | 0.04 | |
Cash per share | 1.97 | 1.42 | 1.32 | 1.2 | 1.16 | |
Book value per share | 3.52 | 2.47 | 2.51 | 2.45 | 2.43 | |
Tangible book value per share | 3.31 | 2.33 | 2.37 | 2.3 | 2.29 | |
Share holders equity per share | 3.52 | 2.47 | 2.51 | 2.45 | 2.43 | |
Interest debt per share | 0.05 | 0.03 | 0.02 | 0.02 | 0.02 | |
Market cap | 2.68B | 3.85B | 4.33B | 4.64B | 4.23B | |
Enterprise value | 2.16B | 3.36B | 3.97B | 4.26B | 3.91B | |
P/E ratio | 15.69 | 11.7 | 23.37 | 25.19 | 23.99 | |
Price to sales ratio | 8.44 | 11.17 | 23.96 | 18.12 | 14.14 | |
POCF ratio | 62.75 | 46.79 | 93.47 | -613.76 | 59.32 | |
PFCF ratio | -10.67K | 73.27 | 442.46 | -159.37 | 95.57 | |
P/B Ratio | 0.95 | 1.34 | 1.49 | 1.64 | 1.5 | |
PTB ratio | 0.95 | 1.34 | 1.49 | 1.64 | 1.5 | |
EV to sales | 6.81 | 9.74 | 21.95 | 16.63 | 13.07 | |
Enterprise value over EBITDA | 15.01 | 37.15 | 188.09 | 75.86 | 38.43 | |
EV to operating cash flow | 50.61 | 40.81 | 85.64 | -563.25 | 54.83 | |
EV to free cash flow | -8.6K | 63.92 | 405.4 | -146.25 | 88.33 | |
Earnings yield | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | |
Free cash flow yield | 0 | 0.01 | 0 | -0.01 | 0.01 | |
Debt to equity | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Debt to assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Net debt to EBITDA | -3.6 | -5.44 | -17.2 | -6.8 | -3.15 | |
Current ratio | 4.94 | 4.71 | 5.25 | 5.01 | 4.85 | |
Interest coverage | 12.31 | -97.76 | -62.97 | 0 | 0 | |
Income quality | 1 | 1 | 1 | -0.16 | 1.62 | |
Dividend Yield | 0 | 0 | 0 | 0.02 | 0.01 | |
Payout ratio | 0 | 0 | 0 | 2.51 | 1.31 | |
Sales general and administrative to revenue | 0.08 | -0.05 | 0.07 | 0 | 0.11 | |
Research and developement to revenue | 0.07 | 0.07 | 0.11 | 0.08 | 0.09 | |
Intangibles to total assets | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | |
Capex to operating cash flow | -1.01 | -0.36 | -0.79 | 2.85 | -0.38 | |
Capex to revenue | -0.14 | -0.09 | -0.2 | -0.08 | -0.09 | |
Capex to depreciation | -4.85 | -3.37 | -3.58 | -2.11 | 1.4 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 2.05 | 1.99 | 1.5 | 1.48 | 1.45 | |
ROIC | 0.04 | 0.03 | 0.02 | 0.02 | 0.02 | |
Return on tangible assets | 0.01 | 0.03 | 0.01 | 0.01 | 0.01 | |
Graham Net | 2.05 | 1.43 | 1.39 | 1.3 | 1.27 | |
Working capital | 1.98B | 1.98B | 1.96B | 1.91B | 1.87B | |
Tangible asset value | 2.65B | 2.7B | 2.75B | 2.66B | 2.65B | |
Net current asset value | 1.95B | 1.95B | 1.93B | 1.88B | 1.84B | |
Invested capital | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Average receivables | 574.6M | 574.42M | 565.04M | 580.66M | 622.72M | |
Average payables | 340.1M | 347.09M | 345.05M | 329.39M | 331.61M | |
Average inventory | 339.61M | 312.69M | 297.71M | 314.36M | 320.09M | |
Days sales outstanding | 163.7 | 149.11 | 278.08 | 212.01 | 193.39 | |
Days payables outstanding | 171.78 | 165.61 | 281.46 | 197.49 | 182.7 | |
Days of inventory on hand | 171.29 | 134.47 | 258.54 | 195.54 | 171.87 | |
Receivables turnover | 0.55 | 0.6 | 0.32 | 0.42 | 0.47 | |
Payables turnover | 0.52 | 0.54 | 0.32 | 0.46 | 0.49 | |
Inventory turnover | 0.53 | 0.67 | 0.35 | 0.46 | 0.52 | |
ROE | 0.02 | 0.03 | 0.02 | 0.02 | 0.02 | |
Capex per share | -0.05 | -0.03 | -0.03 | -0.02 | -0.02 |
300259.SZ Frequently Asked Questions
What is Suntront Technology Co., Ltd. stock symbol ?
Suntront Technology Co., Ltd. is a CN stock and trading under the symbol 300259.SZ
What is Suntront Technology Co., Ltd. stock quote today ?
Suntront Technology Co., Ltd. stock price is $3.24 today.
Is Suntront Technology Co., Ltd. stock public?
Yes, Suntront Technology Co., Ltd. is a publicly traded company.